Mostrando 4 resultados de: 4
Publisher
Acta Tropica(1)
Antimicrobial Agents and Chemotherapy(1)
Journal of Molecular Diagnostics(1)
PLoS Neglected Tropical Diseases(1)
Área temáticas
Enfermedades(3)
Anatomía humana, citología, histología(1)
Farmacología y terapéutica(1)
Fisiología humana(1)
Medicina forense; incidencia de enfermedades(1)
Área de conocimiento
Infección(3)
Biología molecular(1)
Inmunología(1)
Medicina interna(1)
Microbiología(1)
Origen
scopus(4)
Analytical validation of quantitative real-time PCR methods for quantification of trypanosoma cruzi DNA in blood samples from chagas disease patients
ArticleAbstract: An international study was performed by 26 experienced PCR laboratories from 14 countries to assessPalabras claves:Autores:Alberti A., Alvarez-Martínez M., Aznar C., Bisio M., Crisante G.E., Cruz-Robles D., Cura C.I., Da Câmara A.C.J., Da Cruz Moreira O., de Noya B.A., De Paoli de Carvalho Britto C.F., Diosque P., Espinoza B., Flores-Chávez M.D., Greif G., Guhl F., Jaime Alfredo Costales, Juiz N., Marcet P.L., Marcos Da Matta Guedes P., Maria Da Cunha Galvão L., Martínez N.E., Muñoz-Calderón A., Padilla C., Parrado R., Pavia P., Peneau J., Pérez-Morales D., Puerta C., Ramírez J.C., Ramírez J.D., Riarte A., Ribeiro I., Sánchez Z., Santalla J., Schijman A.G., Silva E.L., Sosa-Estani S., Valencia E., Velázquez E., Villarroel R., Villarroel S., Yadón Z.E., Zulantay I.Fuentes:scopusTowards a paradigm shift in the treatment of chronic chagas disease
ReviewAbstract: Treatment for Chagas disease with currently available medications is recommended universally only foPalabras claves:Autores:Araujo-Jorge T., de Noya B.A., Gascón J., Guhl F., López M.C., Mario J. Grijalva, Ramsey J.M., Ribeiro I., Schijman A.G., Sosa-Estani S., Torrico F., Viotti R.Fuentes:scopusSerological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
ArticleAbstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldwPalabras claves:3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZIAutores:Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.Fuentes:scopusTarget product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus
ArticleAbstract:Palabras claves:Autores:Abril M., Almeida I.C., Alonso-Padillaid J., Angheben A., Carmen Thomas M., Chatelain E., de Noya B.A., Esteva M., Gascón J., Guhl F., Hasslochermoreno A.M., Jorge T.A., López M.C., Luquetti A.O., Mario J. Grijalva, Noya O., Picado A., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Schijman A.G., Sosa-Estani S., Torrico F., Zreinid M.Fuentes:scopus